Skip to main content
logo
Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
4.710
-0.560 (-10.63%)
At close: Aug 21, 2026

Curanex Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
2.944.970.150.070
Cash & Short-Term Investments
2.944.970.150.070
Cash Growth
2599.26%3240.12%100.21%2960.33%-
Other Receivables
----0
Receivables
----0
Inventory
----0
Prepaid Expenses
1.856.250--
Other Current Assets
--0.37-0
Total Current Assets
4.7911.230.520.070.01
Property, Plant & Equipment
0.280.35---
Total Assets
5.0711.580.520.070.01

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
000.01--
Accrued Expenses
0.010.010.010.01-
Current Portion of Leases
0.090.12---
Total Current Liabilities
0.10.140.010.01-
Long-Term Leases
0.180.22---
Total Liabilities
0.290.360.010.01-

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
00000
Additional Paid-In Capital
16.0716.060.920.120.05
Retained Earnings
-11.29-4.85-0.62-0.26-0.24
Comprehensive Income & Other
--0.20.20.2
Total Common Equity
4.7911.220.50.060.01
Shareholders' Equity
4.7911.220.50.060.01
Total Liabilities & Equity
5.0711.580.520.070.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
0.280.35---
Net Cash (Debt)
2.664.630.150.070
Net Cash Growth
-3007.26%100.21%2960.33%-
Net Cash Per Share
0.103.630.222.480.08
Filing Date Shares Outstanding
31.361.421.20.030.03
Total Common Shares Outstanding
28.361.421.20.030.03
Working Capital
4.6911.090.50.060.01
Book Value Per Share
0.177.920.422.000.34
Tangible Book Value
4.7911.220.50.060.01
Tangible Book Value Per Share
0.177.920.422.000.34
SEC Filings: 10-K · 10-Q